Assessment of the human kynurenine pathway: Comparisons and clinical implications of ethnic and gender differences in plasma tryptophan, kynurenine metabolites, and enzyme expressions at baseline and after acute tryptophan loading and depletion

International Journal of Tryptophan Research

Volumn 9, Issue 1, 2016, Pages 31-49

  Badawy, Abdulla A B ^a   Dougherty, Donald M ^b  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b University of Texas Health Science Center   (United States)

Author keywords

Acute tryptophan loading and depletion; Ethnicity and gender; Kynurenic acid; Kynureninase; Kynurenine aminotransferase; Tryptophan 2,3 dioxygenase; Tryptophan oxidation

Indexed keywords

EID: 85009834079     PISSN: None     EISSN: 11786469     Source Type: Journal    
DOI: 10.4137/IJTR.S38189     Document Type: Article

References (72)

1. Bender DA. Biochemistry of tryptophan in health and disease. Mol Aspects Med. 1983;6:1-97.
2. Badawy AA-B. Tryptophan metabolism in alcoholism. Nutr Res Rev. 2002;1:123-52.
3. Kanai M, Funakoshi H, Takahashi H, et al. Tryptophan 2, 3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behaviour in mice. Mol Brain. 2009;2:8.
4. Badawy AA-B. Tryptophan metabolism, disposition and utilization in pregnancy. Biosci Rep. 2015;35:e00261.
5. Yeung AWS, Terentis AC, King NC, Thomas SR. Role of indoleamine 2, 3-dioxygenase in health and disease. Clin Sci. 2015;129:601-72.
6. Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N, Dougherty DM. L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int J Tryptophan Res. 2009;2:45-60.
7. Badawy AA-B. Tryptophan: the key to boosting brain serotonin synthesis in depressive illness. J Psychopharmacol. 2013;27:878-93.
8. Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov. 2002;1:1-13.
9. Chen Y, Guillemin GJ. Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res. 2009;2:1-19.
10. Linderholm KR, Skogh E, Olsson SK, et al. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr Bull. 2012;38: 426-32.
11. Mondelli V, Howes O. Editorial: inflammation: its role in schizophrenia and the potential of anti-inflammatory effects of antipsychotics. Psychopharmacol. 2014;231:317-8.
12. Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol. 2003;81:247-65.
13. Michael AF, Drummond KW, Doeden D, Anderson JA, Good RA. Tryptophan metabolism in man. J Clin Invest. 1964;43:1730-46.
14. Price JM, Brown RR, Yess N. Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites. Adv Metab Disord. 1965;2:159-225.
15. Green AR, Bloomfield MR, Woods HF, Seed M. Metabolism of an oral tryptophan load by women and evidence against the induction of tryptophan pyrrolase by oral contraceptives. Br J Clin Pharmacol. 1978;5:233-41.
16. Green AR, Aronson JK, Curzon G, Woods HF. Metabolism of an oral tryptophan load. I: effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol. 1980;10:603-10.
17. Møller SE. Pharmacokinetics of tryptophan, renal handling of kynurenine and the effect of nicotinamide on its appearance in plasma and urine following L-tryptophan loading of healthy subjects. Eur J Clin Pharmacol. 1981;21:137-42.
18. Badawy AA-B, Morgan CJ. Rapid isocratic liquid chromatographic separation and quantification of tryptophan and six kynurenine metabolites in biological samples with ultraviolet and fluorimetric detection. Int J Tryptophan Res. 2010;3:175-86.
19. Mackay GM, Forrest CM, Stoy N, Christofides J, Egerton M, Stone TW. Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol. 2005;12:1-13.
20. Stoy N, Mackay G, Forrest CM, et al. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem. 2005;9:611-23.
21. Young SN, Smith SE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacol. 1985;87:173-7.
22. Badawy AA-B, Lake SL, Dougherty DM. Mechanisms of the pellagragenic effect of leucine: stimulation of hepatic tryptophan oxidation by administration of branched-chain amino acids to healthy human volunteers and the role of plasma free tryptophan and total kynurenines. Int J Tryptophan Res. 2014;7:23-32.
23. Badawy AA-B, Evans M. The regulation of rat liver tryptophan pyrrolase by its cofactor haem-experiments with haematin and 5-aminolaevulinate and comparison with the substrate and hormonal mechanisms. Biochem J. 1975;150:511-20.
24. Badawy AA-B, Welch AN, Morgan CJ. Tryptophan pyrrolase in haem regulation: the mechanism of the opposite effects of tryptophan on rat liver 5-aminolaevulinate synthase activity and the haem saturation of tryptophan pyrrolase. Biochem J. 1981; 198:309-14.
25. Nishiziwa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94:5308-13.
26. Dougherty DM, Marsh-Richard DM, Mathias W, et al. Comparison of 50-and 100-g L-tryptophan depletion and loading formulations for altering 5-HT synthesis: pharmacokinetics, side-effects and mood states. Psychopharmacol. 2008;198:431-45.
27. Badawy AA-B, Dougherty DM, Richard DM. Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests II. Normalisation of the tryptophan and the tyrosine plus phenylalanine to competing amino acid ratios in a new control formulation. Int J Tryptophan Res. 2010;3:35-47.
28. Badawy AA-B. Plasma free tryptophan revisited: what you need to know and do before measuring it. J Psychopharmacol. 2010;24:809-15.
29. Midttun Ø, Hustad S, Ueland PM. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009;23:1371-9.
30. Smith SA, Pogson CI. The metabolism of L-tryptophan by isolated rat liver cells: effect of albumin binding and amino acid competition on oxidation of tryptophan by tryptophan 2, 3-dioxygenase. Biochem J. 1980;186:977-86.
31. Ohashi H, Iizuka H, Yoshihara S, et al. Determination of L-tryptophan and L-kynurenine in human serum by using LC-MS after derivatization with (R)-DBD-PyNCS. Int J Tryptophan Res. 2013;3(Suppl 1):9-14.
32. Rios-Avila L, Nijhout HF, Reed MC, Sitren HS, Gregory JF III. A mathematical model of tryptophan metabolism via the kynurenine pathway provides insights into effects of vitamin B-6 deficiency, tryptophan loading, and induction of tryptophan 2, 3-dioxygenase on tryptophan metabolites. J Nutr. 2013;143:1509-19.
33. da Silva VR, Rios-Avila L, Lamers Y, et al. Metabolite profile analysis reveals functional effects of 28-day vitamin B-6 restriction on one-carbon metabolism and tryptophan catabolic pathways in healthy men and women. J Nutr. 2013;143: 1719-27.
34. Ulvik A, Theofylaktopoulou D, Midttun Ø, Nygård O, Eusson SJ, Ueland PM. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. Am J Clin Nutr. 2013;98:934-40.
35. Badawy AA-B, Dougherty DM, Marsh-Richard DM, Steptoe A. Activation of liver tryptophan pyrrolase mediates the decrease in tryptophan availability to the brain after acute alcohol consumption by normal subjects. Alcohol Alcohol. 2009;4:267-71.
36. Inada J, Okuno E, Kimura M, Kido R. Intracellular localization and characterization of 3-hydroxykynureninase in human liver. Int J Biochem. 1984;16:623-8.
37. Takeuchi F, Shibata Y. Kynurenine metabolism in vitamin-B-6-deficient rat liver after tryptophan injection. Biochem J. 1984;220:693-9.
38. Bender DA. Inhibition in vitro of the enzymes of the oxidative pathway of tryptophan metabolism and of nicotinamide nucleotide synthesis by benserazide, cabidopa and isoniazid. Biochem Pharmacol. 1980;29:707-12.
39. Shibata K, Marugami M, Kondo T. In vivo inhibition of kynurenine aminotransferase activity by isonicotinic acid hydrazide in rats. Biosci Biotechnol Biochem. 1996;60:874-6.
40. Pawlak D, Tankiewicz A, Matys T, Buczko W. Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J Physiol Pharmacol. 2003;5:175-89.
41. Salter M, Bender DA, Pogson CI. Leucine and tryptophan metabolism in rats. Biochem J. 1985;225:277-81.
42. Darlington LG, Forrest CM, Mackay GM, Smith RA, Smith AJ, Stone TW. On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio. Int J Tryptophan Res. 2010;3:51-9.
43. Bender DA, Tagoe CE, Vale JA. Effects of oestrogen administration on vitamin B6 and tryptophan metabolism in the rat. Br J Nutr. 1982;47:609-14.
44. Mason M, Manning B. Effects of steroid conjugates on availability of pyridoxal phosphate for kynureninase and kynurenine aminotransferase. Am J Clin Nutr. 1971;24:786-91.
45. Knox WE. The relation of kynureninase to tryptophan metabolism in pyridoxine deficiency. Biochem J. 1953;5:379-85.
46. Aleman A, Kahn RS, Selten J-P. Sex differences in the risk of schizophrenia. Arch Gen Psychiat. 2003;60:565-71.
47. Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis. Schizophr Res Treatment. 2012;2012:916198.
48. Wu YC, Hill RA, Gogos A, Van den Buse M. Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF. Neuroscience. 2013;23:67-83.
49. Ramos-Loyo J, Medina-Hernández V, Estarrón-Espinosa M, Canales-Aguirre A, Gómez-Pinedo U, Cerdán-Sánchez LF. Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013;44:S154-61.
50. Stone W. The neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 1993;45:309-85.
51. Sathyasaikumar KV, Stachowski EK, Wonodi I, et al. Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr Bull. 2011;37:1147-56.
52. Wu H-Q, Okuyama M, Kajii Y, Pocivavsek A, Bruno JP, Schwarcz R. Targeting kynurenine aminotransferase II in psychiatric diseases: promising effect of an orally active enzyme inhibitor. Schizophr Bull. 2014;40(suppl 2):S2152-8.
53. Dehlendorf C, Park SY, Emeremni AA, Comer D, Vincent K, Borrero S. Racial/ethnic disparities in contraceptive use: variation by age and women's reproductive experiences. Am J Obstet Gynecol. 2014;210(6):526.e1-526.e9.
54. Borrero S, Zhao X, Mor MK, Schwarz EB, Good CB, Gellad WF. Adherence to hormonal contraception among women veterans: differences by race/ethnicity and contraceptive supply. Am J Obstet Gynecol. 2013;20:103e111.
55. Bresnahan M, Begg MD, Brown A, et al. Race and risk of schizophrenia in a US birth cohort: another example of health disparity? Int J Epidemiol. 2007;36:751-8.
56. Neighbors HW, Trierweiler SJ, Ford B, Muroff JR. Racial differences in DSM diagnosis using a semi-structured instrument: the importance of clinical judgment in the diagnosis of African Americans. J Health Soc Behav. 2003;43:237-56.
57. Fearon P, Kirkbridge JB, Morgan C, et al; AESOP Study Group. Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med. 2006;36:1541-50.
58. Aloia JF. African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr. 2008;88(Suppl):545S-50S.
59. Badawy AA-B, Bano S. Tryptophan metabolism in rat liver after administration of tryptophan, kynurenine metabolites and kynureninase inhibitors. Int J Tryptophan Res. 2016:9. [In press].
60. Huether G, Hajak G, Reimer A, et al. The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacology (Berl). 1992;109:422-32.
61. Yuwiler A, Brammer GL, Morley JE, Raleigh MJ, Flannery JW, Geller E. Short-term and repetitive administration of oral tryptophan in normal men. Arch Gen Psychiatry. 1981;38:619-26.
62. Delgado P, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 1990;47:411-4.
63. Salter M, Pogson CI, Bender DA. Leucine and tryptophan metabolism in rats. Biochem J. 1985;225:277-81.
64. Osagawara N, Hagino Y, Kotake Y. Kynurenine aminotransferase, kynureninase and the increase in xanthurenic acid excretion. J Biochem. 1962;52:162-6.
65. Walsh HA, Botting NP. Purification and biochemical characterization of some of the properties of recombinant human kynureninase. Eur J Biochem. 2002;269: 2069-74.
66. Allegri G, Costa C, De Antoni A. A further contribution to the choice of the dose for tryptophan load test. Acta Vitaminol Enzymol. 1978;32:163-6.
67. Han Q, Robinson H, Cai T, Tagle DA, Li J. Structural insight into the inhibition of human kynurenine aminotransferase I/glutamine transaminase K. J Med Chem. 2009;52:2786-93.
68. Stanley JC, Nicholas AR, Dickson AJ, Thompson IN, Pogson CI. Tryptophan aminotransferase activity in rat liver. Biochem J. 1984;220:341-4.
69. Richards P, Brown CL, Lowe SM. Synthesis of tryptophan from 3-indolepyruvic acid by a healthy woman. J Nutr. 1972;102:1547-50.
70. Politi V, D'Alessioi S, Stazio G, De Luca G. Antioxidant properties of indole-3-pyruvic acid. Adv Exp Med Biol. 1996;398:291-8.
71. Han Q, Cai T, Tagle DA, Robinson H, Li J. Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep. 2008;28:205-15.
72. Badawy AA-B. Pellagra and alcoholism: a biochemical perspective. Alcohol Alcohol. 2014;49:238-50.